Incorporating ion channel expression profiling,142 such as that of Piezo1, into tumour biopsy analysis or through emerging liquid biopsy approaches,143,144 could also represent a future opportunity to stratify patients with brain tumours most likely to benefit from FUS-based therapies. Here, PIEZO1 is linked to neoplasm.